CPF FUNDED GRANT DETAILS

The goal of this project is to determine the feasibility of pharmacogenomic testing in a community pharmacy setting using clopidogrel as an example. The objectives of this project are to: identify how many patients on clopidogrel are willing to participate in pharmacogenomics testing, identify the number of patients that know why they are taking clopidogrel, determine the number of interventions that prescribers accept from pharmacist based on the result of the pharmacogenomic testing, determine the amount of time required for the pharmacist to conduct the pharmacogenomic testing and carryout an intervention with the prescriber, assess patient satisfaction and knowledge of pharmacogenomic testing, determine the cost of pharmacogenomic testing for clopidogrel, and to determine the number of patients that are on other medications that are metabolized by CYP2C19.We are also planning to increase awareness of pharmacogenomincs among all pharmacists with Kerr Drug by providing a live CE.